InvestorsHub Logo

Moose412

06/11/22 2:48 AM

#181 RE: Amatuer17 #170

I personally disapprove of begging questions, and stick that there also is no purpose in debating or postulating future ownership of these therapies. That being said, god help those who try to trade biotech.

BLUE may look like a small cap. IMO, it is not. The comparative valuation of BLUE to TSVT is a wild time, and JOMG. One should watch the AdComm meetings - they are amazingly informative.

These E-trade analyst rec's are hilarious.....